{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:07:24Z","timestamp":1789168044266,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,15]]},"DOI":"10.7759\/cureus.54275","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T06:58:52Z","timestamp":1708066732000},"source":"Crossref","is-referenced-by-count":10,"title":["Navigating the Cytokine Storm: A Comprehensive Review of Chemokines and Cytokines in Sepsis"],"prefix":"10.7759","author":[{"given":"Harshitha","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitanya Kumar","family":"Javvaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suprit","family":"Malali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourya","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saket","family":"Toshniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Sepsis. (2023). Accessed. December 20, 2023: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sepsis."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130327","article-title":"The pathogenesis of sepsis","volume":"6","author":"Stearns-Kurosawa DJ","year":"2011","unstructured":"Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol. 2011, 6:19-48. 10.1146\/annurev-pathol-011110-130327","journal-title":"Annu Rev Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.628302","article-title":"Sepsis\u2014pathophysiology and therapeutic concepts","volume":"8","author":"Jarczak D","year":"2021","unstructured":"Jarczak D, Kluge S, Nierhaus A. Sepsis\u2014pathophysiology and therapeutic concepts. Front Med (Lausanne). 2021, 8:628302. 10.3389\/fmed.2021.628302","journal-title":"Front Med (Lausanne)"},{"key":"ref4","unstructured":"What Is Sepsis or Septicemia (Blood Infection)?. (2023). Accessed. December 20, 2023: http:\/\/webmd.com\/a-to-z-guides\/sepsis-septicemia-blood-infection."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4161\/viru.25436","article-title":"Host innate immune responses to sepsis","volume":"5","author":"Wiersinga WJ","year":"2014","unstructured":"Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence. 2014, 5:36-44. 10.4161\/viru.25436","journal-title":"Virulence"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/165974","article-title":"Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view","volume":"2013","author":"Schulte W","year":"2013","unstructured":"Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm. 2013, 2013:165974. 10.1155\/2013\/165974","journal-title":"Mediators Inflamm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes CE","year":"2018","unstructured":"Hughes CE, Nibbs RJ. A guide to chemokines and their receptors. FEBS J. 2018, 285:2944-71. 10.1111\/febs.14466","journal-title":"FEBS J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.147","article-title":"Role of chemokine systems in cancer and inflammatory diseases","volume":"3","author":"Li H","year":"2022","unstructured":"Li H, Wu M, Zhao X. Role of chemokine systems in cancer and inflammatory diseases. MedComm (2020). 2022, 3:e147. 10.1002\/mco2.147","journal-title":"MedComm (2020)"},{"key":"ref9","unstructured":"Chemokine types. (2023). Accessed. December 20, 2023: https:\/\/www.news-medical.net\/health\/Chemokine-Types.aspx."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2011.03485.x","article-title":"Mechanisms regulating chemokine receptor activity","volume":"134","author":"Bennett LD","year":"2011","unstructured":"Bennett LD, Fox JM, Signoret N. Mechanisms regulating chemokine receptor activity. Immunology. 2011, 134:246-56. 10.1111\/j.1365-2567.2011.03485.x","journal-title":"Immunology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.medine.2012.09.008","article-title":"Role of circulating soluble chemokines in septic shock","volume":"37","author":"de Pablo R","year":"2013","unstructured":"de Pablo R, Monserrat J, Prieto A, \u00c1lvarez-Mon M. Role of circulating soluble chemokines in septic shock. Med Intensiva. 2013, 37:510-8. 10.1016\/j.medine.2012.09.008","journal-title":"Med Intensiva"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02748-8","article-title":"Apoptotic cell therapy for cytokine storm associated with acute severe sepsis","volume":"11","author":"Karbian N","year":"2020","unstructured":"Karbian N, Abutbul A, El-Amore R, Eliaz R, Beeri R, Reicher B, Mevorach D. Apoptotic cell therapy for cytokine storm associated with acute severe sepsis. Cell Death Dis. 2020, 11:535. 10.1038\/s41419-020-02748-8","journal-title":"Cell Death Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman BG","year":"2017","unstructured":"Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017, 39:517-28. 10.1007\/s00281-017-0639-8","journal-title":"Semin Immunopathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911740","article-title":"Cytokine storm\u2014definition, causes, and implications","volume":"23","author":"Jarczak D","year":"2022","unstructured":"Jarczak D, Nierhaus A. Cytokine storm\u2014definition, causes, and implications. Int J Mol Sci. 2022, 23:11740. 10.3390\/ijms231911740","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum DC","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020, 383:2255-73. 10.1056\/NEJMra2026131","journal-title":"N Engl J Med"},{"key":"ref16","unstructured":"Pro-inflammatory cytokines overview. (2023). Accessed. December 14, 2023: https:\/\/www.thermofisher.com\/in\/en\/home\/life-science\/cell-analysis\/cell-analysis-learning-center\/immunology-at-work\/p...."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang JM","year":"2007","unstructured":"Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007, 45:27-37. 10.1097\/AIA.0b013e318034194e","journal-title":"Int Anesthesiol Clin"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118074","article-title":"Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines","volume":"96","author":"De Caterina R","year":"1995","unstructured":"De Caterina R, Libby P, Peng HB, et al.. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995, 96:60-8. 10.1172\/JCI118074","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00331.x","article-title":"Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy","volume":"157","author":"Luheshi NM","year":"2009","unstructured":"Luheshi NM, Rothwell NJ, Brough D. Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy. Br J Pharmacol. 2009, 157:1318-29. 10.1111\/j.1476-5381.2009.00331.x","journal-title":"Br J Pharmacol"},{"key":"ref20","unstructured":"Anti-inflammatory cytokines list. (2023). Accessed. December 14, 2023: https:\/\/www.sinobiological.com\/resource\/cytokines\/all-anti-inflammatory-cytokines."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1215\/S1152851704001061","article-title":"The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis","volume":"7","author":"Brat DJ","year":"2005","unstructured":"Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 2005, 7:122-33. 10.1215\/S1152851704001061","journal-title":"Neuro Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/0022034512437372","article-title":"Control of cytokine mRNA expression by RNA-binding proteins and microRNAs","volume":"91","author":"Palanisamy V","year":"2012","unstructured":"Palanisamy V, Jakymiw A, Van Tubergen EA, D'Silva NJ, Kirkwood KL. Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J Dent Res. 2012, 91:651-8. 10.1177\/0022034512437372","journal-title":"J Dent Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-021-01274-5","article-title":"Systematic investigation of cytokine signaling activity at the tissue and single-cell levels","volume":"18","author":"Jiang P","year":"2021","unstructured":"Jiang P, Zhang Y, Ru B, et al.. Systematic investigation of cytokine signaling activity at the tissue and single-cell levels. Nat Methods. 2021, 18:1181-91. 10.1038\/s41592-021-01274-5","journal-title":"Nat Methods"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.06.040188.002255","article-title":"Regulation of cytokine gene expression","volume":"6","author":"Taniguchi T","year":"1988","unstructured":"Taniguchi T. Regulation of cytokine gene expression. Annu Rev Immunol. 1988, 6:439-64. 10.1146\/annurev.iy.06.040188.002255","journal-title":"Annu Rev Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-5890(01)00094-3","article-title":"Regulation of cytokine gene transcription in the immune system","volume":"38","author":"Holloway AF","year":"2002","unstructured":"Holloway AF, Rao S, Shannon MF. Regulation of cytokine gene transcription in the immune system. Mol Immunol. 2002, 38:567-80. 10.1016\/s0161-5890(01)00094-3","journal-title":"Mol Immunol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2013.0151","article-title":"Post-transcriptional control of cytokine gene expression in health and disease","volume":"34","author":"Khabar KS","year":"2014","unstructured":"Khabar KS. Post-transcriptional control of cytokine gene expression in health and disease. J Interferon Cytokine Res. 2014, 34:215-9. 10.1089\/jir.2013.0151","journal-title":"J Interferon Cytokine Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/ni1584","article-title":"Post-transcriptional control of cytokine production","volume":"9","author":"Anderson P","year":"2008","unstructured":"Anderson P. Post-transcriptional control of cytokine production. Nat Immunol. 2008, 9:353-9. 10.1038\/ni1584","journal-title":"Nat Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01926","article-title":"Precision immunotherapy for sepsis","volume":"9","author":"Peters van Ton AM","year":"2018","unstructured":"Peters van Ton AM, Kox M, Abdo WF, Pickkers P. Precision immunotherapy for sepsis. Front Immunol. 2018, 9:1926. 10.3389\/fimmu.2018.01926","journal-title":"Front Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2014.01.002","article-title":"The new normal: immunomodulatory agents against sepsis immune suppression","volume":"20","author":"Hutchins NA","year":"2014","unstructured":"Hutchins NA, Unsinger J, Hotchkiss RS, Ayala A. The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med. 2014, 20:224-33. 10.1016\/j.molmed.2014.01.002","journal-title":"Trends Mol Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s001340051129","article-title":"Immunomodulatory therapies in sepsis","volume":"26 Suppl 1","author":"Kox WJ","year":"2000","unstructured":"Kox WJ, Volk T, Kox SN, Volk HD. Immunomodulatory therapies in sepsis. Intensive Care Med. 2000, 26 Suppl 1:S124-8. 10.1007\/s001340051129","journal-title":"Intensive Care Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.10.032","article-title":"Non-conventional immunomodulation in the management of sepsis","author":"Slim MA","year":"2023","unstructured":"Slim MA, Turgman O, van Vught LA, van der Poll T, Wiersinga WJ. Non-conventional immunomodulation in the management of sepsis. Eur J Intern Med. 2023, 10.1016\/j.ejim.2023.10.032","journal-title":"Eur J Intern Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12082892","article-title":"Treatment advances in sepsis and septic shock: modulating pro- and anti-inflammatory mechanisms","volume":"12","author":"Marques A","year":"2023","unstructured":"Marques A, Torre C, Pinto R, Sepodes B, Rocha J. Treatment advances in sepsis and septic shock: modulating pro- and anti-inflammatory mechanisms. J Clin Med. 2023, 12:2892. 10.3390\/jcm12082892","journal-title":"J Clin Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.901433","article-title":"Cytokines as potential biomarkers for differential diagnosis of sepsis and other non-septic disease conditions","volume":"12","author":"Frimpong A","year":"2022","unstructured":"Frimpong A, Owusu ED, Amponsah JA, et al.. Cytokines as potential biomarkers for differential diagnosis of sepsis and other non-septic disease conditions. Front Cell Infect Microbiol. 2022, 12:901433. 10.3389\/fcimb.2022.901433","journal-title":"Front Cell Infect Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.08.660","article-title":"Biomarkers of cytokine storm and inflammation in sepsis, post-covid-19 patients and covid-19 vaccinated individuals","volume":"129","author":"Titov L","year":"2022","unstructured":"Titov L, Trusevich M, Amvrosieva T, Belskaya I, Gorbich Y, DuBuske L. Biomarkers of cytokine storm and inflammation in sepsis, post-covid-19 patients and covid-19 vaccinated individuals. Ann Allergy Asthma Immunol. 2022, 129:S56. 10.1016\/j.anai.2022.08.660","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222313009","article-title":"Pathogenesis and treatment of cytokine storm induced by infectious diseases","volume":"22","author":"Tang XD","year":"2021","unstructured":"Tang XD, Ji TT, Dong JR, et al.. Pathogenesis and treatment of cytokine storm induced by infectious diseases. Int J Mol Sci. 2021, 22:13009. 10.3390\/ijms222313009","journal-title":"Int J Mol Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2014.46.1.1","article-title":"Biomarkers of sepsis","volume":"46","author":"Cho SY","year":"2014","unstructured":"Cho SY, Choi JH. Biomarkers of sepsis. Infect Chemother. 2014, 46:1-12. 10.3947\/ic.2014.46.1.1","journal-title":"Infect Chemother"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30567-5","article-title":"Current gaps in sepsis immunology: new opportunities for translational research","volume":"19","author":"Rubio I","year":"2019","unstructured":"Rubio I, Osuchowski MF, Shankar-Hari M, et al.. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. 2019, 19:422-36. 10.1016\/S1473-3099(19)30567-5","journal-title":"Lancet Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00041-1","article-title":"Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study","volume":"4","author":"Bermejo-Martin JF","year":"2023","unstructured":"Bermejo-Martin JF, Garc\u00eda-Mateo N, Motos A, et al.. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study. Lancet Microbe. 2023, 4:e431-41. 10.1016\/S2666-5247(23)00041-1","journal-title":"Lancet Microbe"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/219659-navigating-the-cytokine-storm-a-comprehensive-review-of-chemokines-and-cytokines-in-sepsis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T06:58:58Z","timestamp":1708066738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/219659-navigating-the-cytokine-storm-a-comprehensive-review-of-chemokines-and-cytokines-in-sepsis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.54275","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,15]]}}}